Home Cart 0 Sign in  

[ CAS No. 122996-47-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 122996-47-8
Chemical Structure| 122996-47-8
Structure of 122996-47-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 122996-47-8 ]

Related Doc. of [ 122996-47-8 ]

Alternatived Products of [ 122996-47-8 ]

Product Details of [ 122996-47-8 ]

CAS No. :122996-47-8 MDL No. :MFCD00151930
Formula : C24H27NO5 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 409.47 Pubchem ID :-
Synonyms :
Chemical Name :(2S,4R)-1-(((9H-Fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2-carboxylic acid

Calculated chemistry of [ 122996-47-8 ]

Physicochemical Properties

Num. heavy atoms : 30
Num. arom. heavy atoms : 12
Fraction Csp3 : 0.42
Num. rotatable bonds : 7
Num. H-bond acceptors : 5.0
Num. H-bond donors : 1.0
Molar Refractivity : 117.03
TPSA : 76.07 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.03 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.3
Log Po/w (XLOGP3) : 3.9
Log Po/w (WLOGP) : 3.9
Log Po/w (MLOGP) : 2.83
Log Po/w (SILICOS-IT) : 3.17
Consensus Log Po/w : 3.42

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -4.67
Solubility : 0.00876 mg/ml ; 0.0000214 mol/l
Class : Moderately soluble
Log S (Ali) : -5.2
Solubility : 0.00261 mg/ml ; 0.00000637 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -5.27
Solubility : 0.00219 mg/ml ; 0.00000535 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 4.55

Safety of [ 122996-47-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 122996-47-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 122996-47-8 ]

[ 122996-47-8 ] Synthesis Path-Downstream   1~18

  • 1
  • [ 771-61-9 ]
  • [ 122996-47-8 ]
  • [ 147836-80-4 ]
YieldReaction ConditionsOperation in experiment
87% With dicyclohexyl-carbodiimide In ethyl acetate at 20℃; for 20h; Inert atmosphere; 3.1 Synthesis of HDP 30.1788 2000 mg (4.88 mmol) FmocN-Hyp(OtBu)OH were dissolved in 35 ml dry ethyl acetate and treated with 904 mg (4.91 mmol) pentafluorophenol, dissolved in 5 ml ethyl acetate, and 1 1 12 mg (5.39 mmol) dicyclohexylcarbodiimide (DCC), dissolved in 5 ml ethyl acetate. After 20 h stirring at room temperature under argon, the precipitated urea was filtered off and washed with etylacetate. The organic solvent was evaporated and the remaining highly viscous colourless oil was dried in high vacuum. Yield: 2.45 g (87%). The sufficiently pure product was used for the next step without further purification. MS (ESI+) found: 576.23 [MH]+; calc: 575.17 (C30H26F5NO5)
67% With dicyclohexyl-carbodiimide In tetrahydrofuran at -20℃; for 3h;
  • 2
  • [ 21304-38-1 ]
  • (2S,4R)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)pyrrolidine-2-carboxylic acid [ No CAS ]
  • [ 1262320-55-7 ]
YieldReaction ConditionsOperation in experiment
Intermediate 21Step 1 -1 To a stirring solution of 4-iodobenzene-1 ,2-diamine (570mg, 2.43mmol) and (2S,4R)-4-tert-butoxy-1 -(9H-fluoren-9-ylmethoxycarbonyl)pyrrolidine-2-carboxylic acid (998 mg, 2.437 mmol) in DMF (7ml_) are added HATU (1.01 g, 2.68mmol), and DIPEA (0.85mL, 4.87mmol) at 0C. The reaction mixture is stirred for 3 hours, diluted with water (10OmL) with fast stirring, and a beige solid crashed out in the mixture. The suspension is filtered to give 1.59 g of solid.; Step 1 -2 The solid is dissolved in acetic acid, stirred overnight at 50C, and concentrated to dryness under vacuum. The residue is purified by flash chromatography on silica gel (EtOAc/Hexanes, 30% to 100%) to give intermediate 21 (1.31 g).
  • 3
  • [ CAS Unavailable ]
  • [ 122996-47-8 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
With 2-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate(V); N-ethyl-N,N-diisopropylamine In dichloromethane; N,N-dimethyl-formamide at 20℃; for 12h; solid phase reaction; 5.2.12. General procedures for coupling of proline/thioproline/hydroxyproline rings to -NHOH functionalized resin General procedure: Example: Synthesis of 23. A solution of Fmoc-l-proline (0.34 g, 1 mmol), HATU (0.38 g, 1 mmol), and DIPEA (348 μl, 2 mmol) in 2 ml of dry DMF/DCM (1:1) was added dropwise on the functionalized resin 19 (0.2 mmol) after Fmoc deprotection via classical procedure (20% Piperidine in DMF for 20 min (×2)). The cartridge was shaked for 12 h at room temperature. After filtration the resin was rinsed with DMF (3 × 5 ml), DCM (3 × 5 ml) and TBME (3 × 5 ml) and finally dried in vacuo.The efficiency of loading (loading yield: 53%) was determined on 3 mg of resin by Fmoc removal analysis (treatment of the resin with piperidine 20% in DMF) and absorbance measurement at 301 nm (UV-vis Spectrophotometer Shimadzu).
  • 4
  • [ 106-95-6 ]
  • [ 122996-47-8 ]
  • [ 221451-12-3 ]
YieldReaction ConditionsOperation in experiment
86% With sodium hydrogencarbonate In N,N-dimethyl-formamide at 50℃; for 20h; Inert atmosphere;
86% With sodium hydrogencarbonate In N,N-dimethyl-formamide at 50℃; for 20h; (2S,4R)-l-((9H-fluoren-9-yl)methyl) 2-allyl 4-(tert-butoxy)pyrrolidine-l ,2-dicarboxylate (Fmoc-Hyp(OtBu)-OAUyl) (2S,4R)-l-((9H-fluoren-9-yl)methyl) 2-allyl 4-(tert-butoxy)pyrrolidine-l ,2-dicarboxylate (Fmoc-Hyp(OtBu)-OAUyl) Fmoc-Hyp(OtBu)OH (24.9 g, 60.8 mmol, 1 eq) was dissolved in DMF (300 mL) at room temperature. Sodium bicarbonate (12.8 g, 152 mmol, 2.5 eq) was added, followed by allyl bromide (25.3 mL, 300 mmol, 4.9 eq). The solution was fitted with an air condenser and heated to 50 °C for 20 hours. It was then cooled to room temperature, diluted with EtOAc, washed with aqueous 1 M HCl, saturated sodium bicarbonate, water and brine. The organic layer was dried with sodium sulfate, filtered and condensed.15 Purification by column chromatography (15 to 33% EtOAc/hexanes) gave Fmoc-Hyp(OtBu)OAllyl (23.42 g, 52.1 mmol, 86%) as a faint yellow oil. FontWeight="Bold" FontSize="10" H NMR (500 MHz, CDC13) δ 7.76 (t, J= 6.3 Hz, 2H), 7.63 - 7.54 (m, 2H), 7.43 - 7.37 (m, 2H), 7.31 (t, J= 7.0 Hz, 2H), 5.99 - 5.79 (m, 1H), 5.39 - 5.18 (m, 2H), 4.66 (d, J= 5.6 Hz, 1H), 4.63 - 4.13 (m, 6H), 3.81 (ddd, J= 16.6, 10.7, 6.2 Hz, 1H), 3.48 - 3.33 (m, 1H), 2.31 - 2.18 (m, 1H), 2.18 - 2.08 (m, 1H), 1.21 (d, J= 11.6 Hz, 9H). 13C NMR (126 MHz, CDC13) (mixture of rotamers) δ 172.49, 155.01, 154.49, 144.31, 144.18, 144.06, 143.84, 141.44, 141.41, 141.36, 131.91, 131.74, 127.80, 127.76, 127.20, 127.16, 125.31, 125.28, 125.11, 120.08, 120.05, 118.93, 118.61, 74.29, 69.37, 68.48, 67.73, 65.86, 58.09, 57.79, 54.01, 53.52, 47.40, 47.28, 38.90, 37.87, 28.41, 28.37. MS (ESI) 450.5 (M+H).
86% With sodium hydrogencarbonate In N,N-dimethyl-formamide at 50℃; for 20h; (2S,4R)-1-((9H-fluoren-9-yl)methyl) 2-allyl 4-(tert-butoxy)pyrrolidine-1,2-dicarboxylate (Fmoc-Hyp(OtBu)-OAllyl) Fmoc-Hyp(OtBu)OH (24.9 g, 60.8 mmol, 1 eq) was dissolved in DMF (300 mL) at room temperature. Sodium bicarbonate (12.8 g, 152 mmol, 2.5 eq) was added, followed by allyl bromide (25.3 mL, 300 mmol, 4.9 eq). The solution was fitted with an air condenser and heated to 50° C. for 20 hours. It was then cooled to room temperature, diluted with EtOAc, washed with aqueous 1 M HCl, saturated sodium bicarbonate, water and brine. The organic layer was dried with sodium sulfate, filtered and condensed.15 Purification by column chromatography (15 to 33% EtOAc/hexanes) gave Fmoc-Hyp(OtBu)OAllyl (23.42 g, 52.1 mmol, 86%) as a faint yellow oil. 1H NMR (500 MHz, CDCl3) δ 7.76 (t, J=6.3 Hz, 2H), 7.63-7.54 (m, 2H), 7.43-7.37 (m, 2H), 7.31 (t, J=7.0 Hz, 2H), 5.99-5.79 (m, 1H), 5.39-5.18 (m, 2H), 4.66 (d, J=5.6 Hz, 1H), 4.63-4.13 (m, 6H), 3.81 (ddd, J=16.6, 10.7, 6.2 Hz, 1H), 3.48-3.33 (m, 1H), 2.31-2.18 (m, 1H), 2.18-2.08 (m, 1H), 1.21 (d, J=11.6 Hz, 9H). 13C NMR (126 MHz, CDCl3) (mixture of rotamers) δ 172.49, 155.01, 154.49, 144.31, 144.18, 144.06, 143.84, 141.44, 141.41, 141.36, 131.91, 131.74, 127.80, 127.76, 127.20, 127.16, 125.31, 125.28, 125.11, 120.08, 120.05, 118.93, 118.61, 74.29, 69.37, 68.48, 67.73, 65.86, 58.09, 57.79, 54.01, 53.52, 47.40, 47.28, 38.90, 37.87, 28.41, 28.37. MS (ESI) 450.5 (M+H).
  • 5
  • [ 104-86-9 ]
  • [ 122996-47-8 ]
  • [ 1448189-39-6 ]
YieldReaction ConditionsOperation in experiment
89% With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In dichloromethane at 4 - 20℃; for 15h;
89% Stage #1: (2S,4R)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)pyrrolidine-2-carboxylic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 4℃; for 0.333333h; Stage #2: 4-chlorobenzylamine In dichloromethane at 4 - 20℃; for 15h; (2S,4i?)-(9H-fluoren-9-yl)methyl 4-(teri-butoxy)-2-((4- chlorobenzyl)carbamoyl)pyrrolidine-l-carboxylate (2S,4i?)-(9H-fluoren-9-yl)methyl 4-(teri-butoxy)-2-((4- chlorobenzyl)carbamoyl)pyrrolidine-l-carboxylate Fmoc-Hyp(OtBu)-OH (1.23 g, 3 mmol, 1 eq) was dissolved in DCM (15 mL) and cooled to 4 °C. EDC (0.69g, 3.6 mmol, 1.2 eq) and HOBt (0.49 g, 3.6 mmol, 1.2 eq) were then added. After 20 minutes, 4-chlorobenzylamine (0.48 mL, 3.9 mmol, 1.3 eq) was added and the solution was allowed to warm slowly to room temperature. After 15 hours, the mixture was diluted with EtOAc and washed with 1M HC1, sodium bicarbonate, water and brine. The organic layer was dried with sodium sulfate, filtered and condensed. Purification by column chromatography (25 to 100% EtOAc/hexanes) gave a white foam (1.42 g, 2.66 mmol, 89%). NMR (400 MHz, CDC13) δ 7.77 (d, J= 7.2 Hz, 2Η), 7.57 (s, 2H), 7.40 (t, J= 7.3 Hz, 2Η), 7.31 (t, J = 7.3 Hz, 2H), 7.17 (dd, J = 27.2, 19.5 Hz, 4H), 4.58 - 3.94 (m, 7H), 3.60 (d, J = 6.7 Hz, 1H), 3.31 (d, J = 6.6 Hz, 1H), 2.50 (s, 1H), 1.96 (s, 1H), 1.28 - 1.10 (m, 9H). 13C NMR (101 MHz, CDCI3) δ 171.54, 156.13, 143.74, 141.32, 136.81, 133.02, 128.79, 128.71, 127.83, 127.12, 125.04, 120.07, 74.15, 69.63, 67.87, 59.17, 53.26, 47.10, 42.72, 36.34, 28.31. MS (ESI) 534.8 (M+H).
89% Stage #1: (2S,4R)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)pyrrolidine-2-carboxylic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 0.333333h; Stage #2: 4-chlorobenzylamine In dichloromethane at 20℃; for 15h; (2S,4R)-(9H-fluoren-9-yl)methyl 4-(tert-butoxy)-2-((4-chlorobenzyl)carbamoyl)pyrrolidine-1-carboxylate Fmoc-Hyp(OtBu)-OH (1.23 g, 3 mmol, 1 eq) was dissolved in DCM (15 mL) and cooled to 4° C. EDC (0.69 g, 3.6 mmol, 1.2 eq) and HOBt (0.49 g, 3.6 mmol, 1.2 eq) were then added. After 20 minutes, 4-chlorobenzylamine (0.48 mL, 3.9 mmol, 1.3 eq) was added and the solution was allowed to warm slowly to room temperature. After 15 hours, the mixture was diluted with EtOAc and washed with 1M HCl, sodium bicarbonate, water and brine. The organic layer was dried with sodium sulfate, filtered and condensed. Purification by column chromatography (25 to 100% EtOAc/hexanes) gave a white foam (1.42 g, 2.66 mmol, 89%). 1 H NMR (400 MHz, CDCl3) δ 7.77 (d, J=7.2 Hz, 2H), 7.57 (s, 2H), 7.40 (t, J=7.3 Hz, 2H), 7.31 (t, J=7.3 Hz, 2H), 7.17 (dd, J=27.2, 19.5 Hz, 4H), 4.58-3.94 (m, 7H), 3.60 (d, J=6.7 Hz, 1H), 3.31 (d, J=6.6 Hz, Hz), 2.50 (s, 1-H), 1.96 (s, 1H), 1.28-1.10 (m, 9H). 13C NMR (101 MHz, CDCl3) δ 171.54, 156.13, 143.74, 141.32, 136.81, 133.02, 128.79, 128.71, 127.83, 127.12, 125.04, 120.07, 74.15, 69.63, 67.87, 59.17, 53.26, 47.10, 42.72, 36.34, 28.31. MS (ESI) 534.8 (M+H).
  • 6
  • [ 672324-91-3 ]
  • [ 122996-47-8 ]
  • [ 1448189-44-3 ]
YieldReaction ConditionsOperation in experiment
65% With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 18h;
65% With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride for 18h; (2S,4/f)-(9H-fluoren-9-yl)methyl 4-(teri-butoxy)-2-((4-(oxazol-5-yI)benzyl)carbamoyl) pyrrolidine-l-carboxylate (2S,4/f)-(9H-fluoren-9-yl)methyl 4-(teri-butoxy)-2-((4-(oxazol-5-yI)benzyl)carbamoyl) pyrrolidine-l-carboxylate To a round bottom flask with stir bar was charged (2S,4 2)-l-(((9H-fluoren-9- yl)methoxy)carbonyl)-4-(teri-butoxy)pyrrolidine-2-carboxylic acid (0.587, 1.4 mmol 1.0 equiv)'EDC (380 mg, 2.0 mmol, 1.4 equiv), HOBt (310 mg, 2.0 mmol, 1.4 equiv) and (4- (oxazol-5-yl)phenyl)methanamine (250 mg, 1.4 mmol, 1.0 equiv). Upon stirring for 18 h the reaction was diluted with 25 ml DCM, and washed with citric acid (2X 50 mL), and saturated NaHC03 (2X 50 mL). The organic layer was dried with Na2S04, concentrated down then purified via silica gel chromatography (DCM to 2% MeOH (0,5 N NH3) to yield 515 mg (65% yield) of product as a viscous oil JH NMR (400 MHz, CDC13) δ 7.89 (s, 1H), 7.85 - 7.70 (m, 2H), 7.68 - 7.49 (m, 4H), 7.47 - 7.37 (m, 2H), 7.35 - 7.20 (m, 5H), 4.54 - 4.35 (m, 4H), 4.35 - 4.14 (m, 2H), 3.72 - 3.58 (m, 1H), 3.49 - 3.27 (m, 1H), 2.53 (s, 1H), 2.00 (dd, J = 8.1, 20.2, 1H), 1.25 (s, 9H); TLC: (9:1 DCM:MeOH (0.5 N NH3)) R^O.5; LRMS (ESI) 565.9(M+H)+.
  • 7
  • [ 1224640-13-4 ]
  • [ 122996-47-8 ]
  • [ 1445984-76-8 ]
YieldReaction ConditionsOperation in experiment
With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide at 20℃; 6 To 1 - cyclopropyl-l,2,3,4-tetrahydroquinoxaline (400 nig, 2.30 mnioi, LOO equiv) in N,N- dimethylformamide (8 mi.) was added (2S,4R)-4-(tert-butoxy)-l-[(9H-fluoren-9- ylmethoxy)carbonyl]pyrrolidme-2-carboxylic acid (940 mg, 2.30 mmol. 1.00 equiv), HATU (1.30 g, 3.42 mmol, 1.50 equiv) and DIEA (444 nig, 3.44 mmol, 1.50 equiv) and the mixture was stirred overnight at room temperature. The resulting solution was diluted with 40 mL of ethyl acetate, washed with 4x30 mL of brine, dried over sodium sulfate, filtered and then concentrated under reduced pressure to afford 1.5 g (crude) of intermediate 6a as a blue solid.
1.5 g With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃;
  • 8
  • [ 672324-91-3 ]
  • [ 122996-47-8 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
65% With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 18h; (2S,4R)-(9H-fluoren-9-yl)methyl 4-(tert-butoxy)-2-((4-(oxazol-5-yl)benzyl)carbamoyl)pyrrolidine-1-carboxylate To a round bottom flask with stir bar was charged (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2-carboxylic acid (0.587, 1.4 mmol 1.0 equiv) EDC (380 mg, 2.0 mmol, 1.4 equiv), HOBt (310 mg, 2.0 mmol, 1.4 equiv) and (4-(oxazol-5-yl)phenyl)methanamine (250 mg, 1.4 mmol, 1.0 equiv). Upon stirring for 18 h the reaction was diluted with 25 ml DCM, and washed with citric acid (2×50 mL), and saturated NaHCO3 (2×50 mL). The organic layer was dried with Na2SO4, concentrated down then purified via silica gel chromatography (DCM to 2% MeOH (0.5 N NH3) to yield 515 mg (65% yield) of product as a viscous oil 1H NMR (400 MHz, CDCl3) δ 7.89 (s, 1H), 7.85-7.70 (m, 2H), 7.68-7.49 (m, 4H), 7.47-7.37 (m, 2H), 7.35-7.20 (m, 5H), 4.54-4.35 (m, 4H), 4.35-4.14 (m, 2H), 3.72-3.58 (m, 1H), 3.49-3.27 (m, 1H), 2.53 (s, 1H), 2.00 (dd, J=8.1, 20.2, 1H), 1.25 (s, 9H); TLC: (9:1 DCM:MeOH (0.5 N NH3)) Rf=0.5; LRMS (ESI) 565. 9(M+H)+.
  • 9
  • [ 1448190-11-1 ]
  • [ 122996-47-8 ]
  • [ 1973409-08-3 ]
YieldReaction ConditionsOperation in experiment
31% With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃; 3 Step 3. Synthesis of 9H-fluoren-9-ylmethyl (2S,4R)-4-(tert-butoxy)-2-({ [2- hydroxy-4-(4-methyl- 1 ,3 -thiazol-5-yl)phenyl]methyl}carbamoyl)pyrrolidine- 1 -carboxylate (BJ) Step 3. Synthesis of 9H-fluoren-9-ylmethyl (2S,4R)-4-(tert-butoxy)-2-({ [2- hydroxy-4-(4-methyl- 1 ,3 -thiazol-5-yl)phenyl]methyl}carbamoyl)pyrrolidine- 1 -carboxylate (BJ)[0461] To a stirred solution of (2S,4R)-4-(tert-butoxy)- l-[(9H-fluoren-9- ylmethoxy)carbonyl]pyrrolidine-2-carboxylic acid (BI, 18.6 g) in N,N-dimethylformamide (250 mL) was added DIEA (7.9 g, 61.24 mmol), HATU (17.3 g, 45.53 mmol) and 2-(aminomethyl)-5- (4-methyl-l,3-thiazol-5-yl)phenol (20 g, 90.79 mmol) at rt. The resulting mixture was stirred overnight at rt, and LC-MS indicated formation of the desired product. The reaction mixture was diluted by water (200 mL) and then extracted with ethyl acetate (300 mL x 3). The organic layers were combined, dried over anhydrous sodium sulfate and concentrated under reduced pressure to give a crude residue, which was purified by flash silica gel chromatography (eluent:dichloromethane/methanol (v: v = 25: 1)) to give BJ (yield: 31%) as a yellow oil. LC-MS (ES+): m/z 611.20 [MH+], tR= 1.12 min (2.0 minute run).
  • 10
  • [ 16874-08-1 ]
  • [ 122996-47-8 ]
  • [ 2090208-86-7 ]
YieldReaction ConditionsOperation in experiment
85% With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 0 - 20℃; for 16h; 9 Example 9. Synthesis of (25,4tf)-(9H-fluoren-9-yl)methyl 4-(feri-butoxy)-2 -(((25,35)- 1- (ieri-butoxy)-3-methyl-l-oxopentan-2-yl)carbamoyl)pyrrolidine-l-carboxylate (8) To a solution of Fmoc-Pro(OiBu)-OH (2.50 g, 6.10 mmol), H-Ile-O'Bu (1.37 g, 7.32 mmol), HOBt (1.12g, 7.32 mmol) in THF (40 mL) was added DIPEA (2.6 mL, 15.3 mmol) at 0 °C, followed by EDC-HCl (1.40 g, 7.32 mmol) in portions. The reaction was warmed to r.t. and stirred for 16 h. After concentration, the residue was diluted with ethyl acetate and washed with 5% citric acid (3 x), saturated NaHC03 (3 x) and brine. The organic phase was dried over anhydrous Na2S04 and concentrated. The residue was purified by column chromatography (0- 20% ethyl acetate/hexanes) to give a white solid (2.55 g, 85% yield). ESI MS m/z 579.3 ([M+H]+).
  • 11
  • N-(Fmoc-glycyl)-5-carboxylic acid-7-nitroindoline [ No CAS ]
  • [ 29022-11-5 ]
  • [ 71989-31-6 ]
  • (2S,4R)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)pyrrolidine-2-carboxylic acid [ No CAS ]
  • C52H60N8O13 [ No CAS ]
YieldReaction ConditionsOperation in experiment
81% Stage #1: N-(Fmoc-glycyl)-5-carboxylic acid-7-nitroindoline In dichloromethane; N,N-dimethyl-formamide for 5h; Stage #2: With acetic acid In dichloromethane; N,N-dimethyl-formamide for 1h; Stage #3: N-(fluoren-9-ylmethoxycarbonyl)glycine; Fmoc-Pro-OH; (2S,4R)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)pyrrolidine-2-carboxylic acid Further stages;
81% Stage #1: N-(Fmoc-glycyl)-5-carboxylic acid-7-nitroindoline In dichloromethane; N,N-dimethyl-formamide for 5h; Automated synthesizer; Stage #2: With piperidine In N,N-dimethyl-formamide for 0.25h; Automated synthesizer; Stage #3: N-(fluoren-9-ylmethoxycarbonyl)glycine; Fmoc-Pro-OH; (2S,4R)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)pyrrolidine-2-carboxylic acid Further stages; 2.B Photoreactive peptide 7. The photoreactive amino acid 6 served as one of the building blocks for the SPPS of the heptamer peptide acid 7 (Scheme 2), needed for the synthesis of the full length photoreactive peptide 1. Diphenyldiazomethane resin (loading capacity 0.7 mmol/g) (0.99 mmol, 1.42 g) was swollen in 10 mL of DCM in a peptide synthesis vessel for 20 min. Compound 6 (1.0 mmol, 0.49 g) was dissolved in a DCM:DMF (2:1) mixture (0.20 M, 5 mL) and added to the resin and shaken for 5 hours in a peptide synthesizer. Upon completion of the coupling, the excess of compound 6 was recovered. The inventors used only 1 equiv. of the first amino acid in order to accomplish a reduced loading to minimize peptide aggregation on the resin. The resin was suspended in 5 mL of glacial acetic acid for 1 hour to cap the remaining diphenyldiazomethane sites. A piperidine in DMF solution (20%) was added (5 mL) and stirred for 15 min. The amount of resin loading was determined to be 47% by the spectrophotometric quantification of dibenzofulvene at 290 nm, ε5253. Fmoc-Pro-OH (5.0 mmol, 1.68 g), N,N,N′,N′-tetramethyl-O-(1H-benzotriazol-1-yl)uronium hexafluorophosphate (HBTU) (5.0 mmol, 1.90 g) and 1-hydroxybenzotriazole hydrate (HOBt) (5 mmol, 0.68 g) were dissolved in DMF (1 M, 5 mL) and N,N-diisopropylethylamine (DIPEA) (10 mmol, 1.75 mL) was added just before the solution was added to the resin. The vessel was shaken for 15 min, followed by NMP washings (5×5 mL) and double coupling of the amino acid was performed (15 min). Any free amino groups potentially still present were capped with 10% Ac2O and 5% DIPEA in DMF (5 mL, 10 min). The synthetic cycle was repeated for each amino acid of the heptamer. Every coupling was monitored until completion through the bromophenol blue and chloranil tests. The latter is preferred for N-terminal proline. The peptide was cleaved from the resin with a 3% trifluoroacetic acid (TFA) solution in DCM (10 mL) for 3 min with 15 repetitions. The acidic solution was concentrated to approximately 5 mL and it was quickly transferred dropwise to cold diethyl ether to obtain a yellow precipitate of a fully protected photoreactive hexamer 7. The suspension was centrifuged and the supernatant decanted. It was then washed several times with cold diethyl ether followed by lyophilization in benzene. The crude peptide was purified by silica gel flash chromatography (gradient of 5% MeOH to 10% MeOH in DCM) to isolate 7 (0.38 g) in 81% yield based on the loading of the first amino acid. Rf=0.1 (MeOH/DCM 5:95). HR-ESI-TOF-MS m/z calcd.: 1005.4358 [M+H]+; obs.: 1005.4334; m/z calcd.: 1027.4178 [M+Na]+; obs. 1027.4176. The normalized absorption spectrum of this compound in DCM (9.95×10-5 M) exhibits two absorption region maxima located at 267 and 327 nm. The fluorescence emission spectra of this compound in DCM (9.95×10-5 M) was recorded in the wavelength range of 330-750 nm and excited by 327 nm exhibiting an emission maximum of 391 nm.
  • 12
  • [ 100-39-0 ]
  • [ 122996-47-8 ]
  • [ 174769-71-2 ]
YieldReaction ConditionsOperation in experiment
100% Stage #1: (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2-carboxylic acid With anhydrous sodium carbonate In N,N-dimethyl-formamide for 0.166667h; Stage #2: benzyl bromide In N,N-dimethyl-formamide at 20℃; for 16h; 1.1.a; 2.7.a; 3.13.a; 1.19 1. Step a: Synthesis of the compound represented by the chemical formula 2 Dissolve Fmoc-Hyp(t-Bu)-OH (the compound shown in chemical formula 1, 50 g, 1.0 eq) in DMF (250 mL), add sodium carbonate (20.25 g) and stir for 10 min, then add benzyl bromide (that is, chemical formula 8) The compound shown, 25.06 g) was reacted at room temperature for 16 h, and after the reaction was completed, celite was filtered. The filtrate was concentrated and separated by column chromatography to obtain the compound represented by chemical formula 2, and the yield was 100%.
With anhydrous sodium carbonate In N,N-dimethyl-formamide at 20℃; for 12h;
With anhydrous sodium carbonate In dichloromethane at 20℃; for 2h; Inert atmosphere; 1.1 Step 1: Dissolve Compound I, Compound II, and sodium carbonate in dichloromethane, fill with nitrogen, react at room temperature for 2h, and spin to obtain Compound III.
  • 13
  • 2-chlorotrityl chloride polystyrene resin [ No CAS ]
  • [ 75932-02-4 ]
  • (2S,4R)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)pyrrolidine-2-carboxylic acid [ No CAS ]
  • C34H41ClN3O4Pol [ No CAS ]
YieldReaction ConditionsOperation in experiment
A 2-chlorotrityl chloride resin (100-200 mesh, Novabiochem 200 mg, 1 eq.), Fmoc-Hyp(tBu)-OH (Fmoc-O-tert-butyl-L-hydroxyproline) (163.8 mg, 2 eq.), and DIPEA (139.3 mul, 4 eq.) dissolved in 5 ml of DCM were added to a 10 ml of reaction vessel, and reacted at room temperature for 12 hours. The reaction solution was removed by filtration, and the synthesized resin was subsequently washed using 10 ml of each of DCM and MeOH, DCM, and DMF, thereby quantitatively obtaining Compound 2a. Step 2. Synthesis of Compound 2b (Fmoc-Lys(Fmoc)-Hyp(tBu)-O-2-chloro trityl Resin) (0158) (0159) 5 ml of 20% piperidine (in DMF) was added to the reaction vessel of step 1 (Compound 2a obtained in step 1), reacted at room temperature for 5 minutes, and filtered to remove the reaction solution. 5 ml of 20% piperidine (in DMF) was added once more, and reacted at room temperature for 5 minutes. The reaction solution was removed by filtration, the synthesized resin was sequentially washed with 10 ml of each of DCM and MeOH, DCM, and DMF, Fmoc-Lys(Fmoc)-OH (472.6 mg, 4 eq.), HOBt (108.1 mg, 4 eq.), and DIC (123.9 mul, 4 eq.) dissolved in 5 ml of DMF were added, and reacted at room temperature for 2 hours. The reaction solution was removed by filtration, and the synthesized resin was subsequently washed using 10 ml of each of DCM and MeOH, DCM, and DMF, thereby quantitatively obtaining Compound 2b. Step 3. Synthesis of Compound 2c (tert-butoxycarbonylmethyl)2-Lys(tert-butoxycarbonylmethyl)2-Hyp(tBu)-O-2-chloro trityl Resin) (0160) (0161) 5 ml of 20% piperidine (in DMF) was added to the reaction vessel of step 2 (Compound 2b obtained in step 2), reacted at room temperature for 5 minutes, and filtered to remove the reaction solution. 5 ml of 20% piperidine (in DMF) was added once more, and reacted at room temperature for 5 minutes. The reaction solution was removed by filtration, the synthesized resin was sequentially washed using 500 ml of each of DCM and MeOH, DCM, and DMF, t-butyl bromoacetate (295.3 mul, 10 eq.) and DIPEA (522b mul, 15 eq.) dissolved in 5 ml of DMF were added, and reacted at room temperature for 48 hours. The reaction solution was removed by filtration, and the synthesized resin was subsequently washed using 10 ml of each of DCM and DMF, and DCM, thereby quantitatively obtaining Compound 2c.
  • 14
  • [ 122996-47-8 ]
  • [ 1027601-37-1 ]
  • [ 2713432-64-3 ]
YieldReaction ConditionsOperation in experiment
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane; N,N-dimethyl-formamide at 25℃; for 1h; 14.2 Step 2: (2S,4R)-(9H-fluoren-9-yl)methyl-4-(tert-butoxy)-2-(((S)-1-methoxy-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)carbamoyl)pyrrolidine-1-carboxylate A mixture of methyl (2S)-2-amino-3-[(3S)-2-oxopyrrolidin-3-yl]propanoate (190 mg, 853.29 umol, 1 eq, HCl), (2S,4R)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)pyrrolidine-2-carboxylic acid (349.40 mg, 853.29 umol, 1 eq), EDCI (327.15 mg, 1.71 mmol, 2 eq), DMAP (208.49 mg, 1.71 mmol, 2 eq), DMF (3 mL) and DCM (6 mL) was stirred at 25° C. for 1 h. The reaction mixture was diluted with H2O (30 mL) and extracted with DCM (30 mL*3). The combined organic layers were washed with brine (50 mL), dried over Na2SO4, filtered and concentrated under reduced pressure to give a residue. The residue was purified by column chromatography (SiO2, petroleum ether/EtOAc=0/1) to get the product (2S,4R)-(9H-fluoren-9-yl)methyl-4-(tert-butoxy)-2-(((S)-1-methoxy-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)carbamoyl)pyrrolidine-1-carboxylate (230 mg, 319.96 umol, 37.50% yield, 80.36% purity), as an oil. MS (ESI) m/z 578.2 [M+H]+
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane; N,N-dimethyl-formamide at 25℃; for 1h; 14.2 Step 2: (2S,4R)-(9H-fluoren-9-yl)methyl-4-(tert-butoxy)-2-(((S)-1-methoxy-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)carbamoyl)pyrrolidine-1-carboxylate A mixture of methyl (2S)-2-amino-3-[(3S)-2-oxopyrrolidin-3-yl]propanoate (190 mg, 853.29 umol, 1 eq, HCl), (2S,4R)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)pyrrolidine-2-carboxylic acid (349.40 mg, 853.29 umol, 1 eq), EDCI (327.15 mg, 1.71 mmol, 2 eq), DMAP (208.49 mg, 1.71 mmol, 2 eq), DMF (3 mL) and DCM (6 mL) was stirred at 25° C. for 1 h. The reaction mixture was diluted with H2O (30 mL) and extracted with DCM (30 mL*3). The combined organic layers were washed with brine (50 mL), dried over Na2SO4, filtered and concentrated under reduced pressure to give a residue. The residue was purified by column chromatography (SiO2, petroleum ether/EtOAc=0/1) to get the product (2S,4R)-(9H-fluoren-9-yl)methyl-4-(tert-butoxy)-2-(((S)-1-methoxy-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)carbamoyl)pyrrolidine-1-carboxylate (230 mg, 319.96 umol, 37.50% yield, 80.36% purity), as an oil. MS (ESI) m/z 578.2 [M+H]+
  • 15
  • [ 1221793-29-8 ]
  • [ CAS Unavailable ]
  • [ 122996-47-8 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
Stage #1: C21H23N2O2PolS; (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2-carboxylic acid With 1-hydroxy-7-aza-benzotriazole; N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide for 2h; Inert atmosphere; Stage #2: With 4-methylpiperidine In N,N-dimethyl-formamide Inert atmosphere; Stage #3: (2S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-(adamantan-1-yl)acetic acid Further stages; S20 4-Formy1-3-methoxy-phenyloxymethyl polystyrene resin (0.100 mmol) was added to a plastic peptide synthesis vessel. 10 mL 1,2-Dichloroethane were added and the resin was allowed to swell for 30 min under nitrogen. The resin was drained under vacuum. (S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethan-1-amine hydrochloride (3.0 equiv.) was added to the plastic reactor. A solution of triethylamine (10.0 equiv.) solution in 1,2-Dichloroethane (1 mL) was prepared. The solution was drawn into the plastic reactor and reacted for 2 hr at room temperature. The reactor was opened, and sodium cyanoborohydride (10.0 equiv.) and acetic acid (2 equiv.) were added to the reactor. The reactor was left opened on manifold, mixed by pipetting, and reacted overnight at RT. The resin was washed by lOmL methanol, 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture of (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2-carboxylic acid (3.0 equiv.), 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (3.0 equiv.), 1-hydroxy-7-azabenzotriazole (3.0 equiv.), and N,N-Diisopropylethylamine (6.0 equiv.) in 10 mL N,N-Dimethylformamide was added; then, the mixture was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 10 mL of 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture of (2S)-2-((((9H-fhioren-9-yl)methoxy)carbonyl)amino)-2-(adamantan-1-yl)acetic acid (3.0 equiv.), Ethyl cyano(hydroxyimino) acetate (3.0 equiv.) and N,N'- Diisopropylcarbodiimide (3.0 equiv.) in 10 mL N,N-Dimethylformamide was added; then, the mixture was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 10 mL of 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 1H- imidazole- 1 -sulfonyl azide hydrochloride (3.0 equiv.) and N,N-Diisopropylethylamine (6.0 equiv.) were mixed in dichloromethane. The mixture was drawn into the reaction vessel and reacted under nitrogen for 1 hr to convert amine to azide. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. Tetrakis(acetonitrile)copper(I) hexafluorophosphate (0.2 equiv.) was added directly into the peptide synthesis vessel to perform on-resin "click" reaction. The mixture of ethynylcyclopropane (5.0 equiv.), N,N-Diisopropylethylamine (10.0 equiv.) in 10 mL N,N-Dimethylformamide (nitrogen purged) was drawn into the reaction vessel and reacted overnight under nitrogen. The resin was washed with 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. A cleavage solution was prepared by mixing 5% Triisopropylsilane in 95% Trifluoroacetic acid. The solution was drawn into the reaction vessel and reacted for 1 hr. The Trifluoroacetic acid was removed under vacuum. The remaining residue was mixed with 50 mL cold ether (-20 °C) to precipitate the compound. The precipitate was collected and separated by reverse phase HPLC (30% - 60% Acetonitrile). The desired product was freeze dried and characterized by LC-MS. ESI-MS: m/z [M+H]+ calculated: 615.3, found: 615.3. [0374] 1H NMR (400 MHz, MeOH-d4) 5 8.98 (s, 1H), 7.97 (d, J = 6.7 Hz, 1H), 7.50 - 7.34 (m, 4H), 5.30 (s, 1H), 5.12 - 4.96 (m, 2H), 4.54 (dd, J = 9.3, 7.6 Hz, 1H), 4.47 - 4.37 (m, 1H), 3.85 (dd, 7 = 11.1, 3.8 Hz, 1H), 3.79 - 3.66 (m, 1H), 2.49 (d, 7 = 3.6 Hz, 3H), 2.20 (ddt, 7 = 11.3, 7.6, 2.0 Hz, 1H), 2.04 - 1.91 (m, 5H), 1.85 - 1.58 (m, 14H), 1.55 (d, 7 = 7.0 Hz, 3H), 1.02 - 0.93 (m, 2H), 0.79 (ddt, 7 = 6.4, 4.9, 2.2 Hz, 2H).
Stage #1: C21H23N2O2PolS; (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2-carboxylic acid With 1-hydroxy-7-aza-benzotriazole; N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide for 2h; Inert atmosphere; Stage #2: With 4-methylpiperidine In N,N-dimethyl-formamide Inert atmosphere; Stage #3: (2S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-(adamantan-1-yl)acetic acid Further stages; S20 4-Formy1-3-methoxy-phenyloxymethyl polystyrene resin (0.100 mmol) was added to a plastic peptide synthesis vessel. 10 mL 1,2-Dichloroethane were added and the resin was allowed to swell for 30 min under nitrogen. The resin was drained under vacuum. (S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethan-1-amine hydrochloride (3.0 equiv.) was added to the plastic reactor. A solution of triethylamine (10.0 equiv.) solution in 1,2-Dichloroethane (1 mL) was prepared. The solution was drawn into the plastic reactor and reacted for 2 hr at room temperature. The reactor was opened, and sodium cyanoborohydride (10.0 equiv.) and acetic acid (2 equiv.) were added to the reactor. The reactor was left opened on manifold, mixed by pipetting, and reacted overnight at RT. The resin was washed by lOmL methanol, 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture of (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2-carboxylic acid (3.0 equiv.), 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (3.0 equiv.), 1-hydroxy-7-azabenzotriazole (3.0 equiv.), and N,N-Diisopropylethylamine (6.0 equiv.) in 10 mL N,N-Dimethylformamide was added; then, the mixture was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 10 mL of 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture of (2S)-2-((((9H-fhioren-9-yl)methoxy)carbonyl)amino)-2-(adamantan-1-yl)acetic acid (3.0 equiv.), Ethyl cyano(hydroxyimino) acetate (3.0 equiv.) and N,N'- Diisopropylcarbodiimide (3.0 equiv.) in 10 mL N,N-Dimethylformamide was added; then, the mixture was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 10 mL of 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 1H- imidazole- 1 -sulfonyl azide hydrochloride (3.0 equiv.) and N,N-Diisopropylethylamine (6.0 equiv.) were mixed in dichloromethane. The mixture was drawn into the reaction vessel and reacted under nitrogen for 1 hr to convert amine to azide. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. Tetrakis(acetonitrile)copper(I) hexafluorophosphate (0.2 equiv.) was added directly into the peptide synthesis vessel to perform on-resin "click" reaction. The mixture of ethynylcyclopropane (5.0 equiv.), N,N-Diisopropylethylamine (10.0 equiv.) in 10 mL N,N-Dimethylformamide (nitrogen purged) was drawn into the reaction vessel and reacted overnight under nitrogen. The resin was washed with 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. A cleavage solution was prepared by mixing 5% Triisopropylsilane in 95% Trifluoroacetic acid. The solution was drawn into the reaction vessel and reacted for 1 hr. The Trifluoroacetic acid was removed under vacuum. The remaining residue was mixed with 50 mL cold ether (-20 °C) to precipitate the compound. The precipitate was collected and separated by reverse phase HPLC (30% - 60% Acetonitrile). The desired product was freeze dried and characterized by LC-MS. ESI-MS: m/z [M+H]+ calculated: 615.3, found: 615.3. [0374] 1H NMR (400 MHz, MeOH-d4) 5 8.98 (s, 1H), 7.97 (d, J = 6.7 Hz, 1H), 7.50 - 7.34 (m, 4H), 5.30 (s, 1H), 5.12 - 4.96 (m, 2H), 4.54 (dd, J = 9.3, 7.6 Hz, 1H), 4.47 - 4.37 (m, 1H), 3.85 (dd, 7 = 11.1, 3.8 Hz, 1H), 3.79 - 3.66 (m, 1H), 2.49 (d, 7 = 3.6 Hz, 3H), 2.20 (ddt, 7 = 11.3, 7.6, 2.0 Hz, 1H), 2.04 - 1.91 (m, 5H), 1.85 - 1.58 (m, 14H), 1.55 (d, 7 = 7.0 Hz, 3H), 1.02 - 0.93 (m, 2H), 0.79 (ddt, 7 = 6.4, 4.9, 2.2 Hz, 2H).
Stage #1: C21H23N2O2PolS; (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2-carboxylic acid With 1-hydroxy-7-aza-benzotriazole; N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide for 2h; Inert atmosphere; Stage #2: With 4-methylpiperidine In N,N-dimethyl-formamide Inert atmosphere; Stage #3: (2S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-(adamantan-1-yl)acetic acid Further stages; S20 4-Formy1-3-methoxy-phenyloxymethyl polystyrene resin (0.100 mmol) was added to a plastic peptide synthesis vessel. 10 mL 1,2-Dichloroethane were added and the resin was allowed to swell for 30 min under nitrogen. The resin was drained under vacuum. (S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethan-1-amine hydrochloride (3.0 equiv.) was added to the plastic reactor. A solution of triethylamine (10.0 equiv.) solution in 1,2-Dichloroethane (1 mL) was prepared. The solution was drawn into the plastic reactor and reacted for 2 hr at room temperature. The reactor was opened, and sodium cyanoborohydride (10.0 equiv.) and acetic acid (2 equiv.) were added to the reactor. The reactor was left opened on manifold, mixed by pipetting, and reacted overnight at RT. The resin was washed by lOmL methanol, 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture of (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2-carboxylic acid (3.0 equiv.), 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (3.0 equiv.), 1-hydroxy-7-azabenzotriazole (3.0 equiv.), and N,N-Diisopropylethylamine (6.0 equiv.) in 10 mL N,N-Dimethylformamide was added; then, the mixture was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 10 mL of 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture of (2S)-2-((((9H-fhioren-9-yl)methoxy)carbonyl)amino)-2-(adamantan-1-yl)acetic acid (3.0 equiv.), Ethyl cyano(hydroxyimino) acetate (3.0 equiv.) and N,N'- Diisopropylcarbodiimide (3.0 equiv.) in 10 mL N,N-Dimethylformamide was added; then, the mixture was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 10 mL of 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 1H- imidazole- 1 -sulfonyl azide hydrochloride (3.0 equiv.) and N,N-Diisopropylethylamine (6.0 equiv.) were mixed in dichloromethane. The mixture was drawn into the reaction vessel and reacted under nitrogen for 1 hr to convert amine to azide. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. Tetrakis(acetonitrile)copper(I) hexafluorophosphate (0.2 equiv.) was added directly into the peptide synthesis vessel to perform on-resin "click" reaction. The mixture of ethynylcyclopropane (5.0 equiv.), N,N-Diisopropylethylamine (10.0 equiv.) in 10 mL N,N-Dimethylformamide (nitrogen purged) was drawn into the reaction vessel and reacted overnight under nitrogen. The resin was washed with 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. A cleavage solution was prepared by mixing 5% Triisopropylsilane in 95% Trifluoroacetic acid. The solution was drawn into the reaction vessel and reacted for 1 hr. The Trifluoroacetic acid was removed under vacuum. The remaining residue was mixed with 50 mL cold ether (-20 °C) to precipitate the compound. The precipitate was collected and separated by reverse phase HPLC (30% - 60% Acetonitrile). The desired product was freeze dried and characterized by LC-MS. ESI-MS: m/z [M+H]+ calculated: 615.3, found: 615.3. [0374] 1H NMR (400 MHz, MeOH-d4) 5 8.98 (s, 1H), 7.97 (d, J = 6.7 Hz, 1H), 7.50 - 7.34 (m, 4H), 5.30 (s, 1H), 5.12 - 4.96 (m, 2H), 4.54 (dd, J = 9.3, 7.6 Hz, 1H), 4.47 - 4.37 (m, 1H), 3.85 (dd, 7 = 11.1, 3.8 Hz, 1H), 3.79 - 3.66 (m, 1H), 2.49 (d, 7 = 3.6 Hz, 3H), 2.20 (ddt, 7 = 11.3, 7.6, 2.0 Hz, 1H), 2.04 - 1.91 (m, 5H), 1.85 - 1.58 (m, 14H), 1.55 (d, 7 = 7.0 Hz, 3H), 1.02 - 0.93 (m, 2H), 0.79 (ddt, 7 = 6.4, 4.9, 2.2 Hz, 2H).
  • 16
  • [ 1221793-29-8 ]
  • [ CAS Unavailable ]
  • [ 122996-47-8 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
Stage #1: C21H22ClN2O2PolS; (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2-carboxylic acid With 1-hydroxy-7-aza-benzotriazole; N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide for 2h; Inert atmosphere; Stage #2: With 4-methylpiperidine In N,N-dimethyl-formamide Inert atmosphere; Stage #3: (2S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-(adamantan-1-yl)acetic acid Further stages; S23 4-Formy1-3-methoxy-phenyloxymethyl polystyrene resin (0.100 mmol) was added to a plastic peptide synthesis vessel. 10 mL 1,2-Dichloroethane were added and the resin was allowed to swell for 30 min under nitrogen. The resin was drained under vacuum. 1-[2-chloro-4-(4-methyl-1,3-thiazo1-5-yl)phenyl]ethan-1-amine diHydrochloride (3.0 equiv.) was added to the plastic reactor. A solution of triethylamine (10.0 equiv.) in 1,2-Dichloroe thane (1 mL) was prepared. The solution was drawn into the plastic reactor and reacted for 2 hr at room temperature. The reactor was opened, and sodium cyanoborohydride (10.0 equiv.) and acetic acid (2 equiv.) were added to the reactor. The reactor was left opened on manifold, mixed by pipetting, and reacted overnight at RT. The resin was washed by lOmL methanol, 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture of (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2-carboxylic acid (3.0 equiv.), 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (3.0 equiv.), 1-hydroxy-7-azabenzotriazole (3.0 equiv.), and N,N- Diisopropylethylamine (6.0 equiv.) in 10 mL N,N-Dimethylformamide was added; then, the mixture was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 10 mL of 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture (2S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-(adamantan-1-yl)acetic acid (3.0 equiv.), Ethyl cyano(hydroxyimino) acetate (3.0 equiv.) and N,N'-Diisopropylcarbodiimide (3.0 equiv.) in 10 mL N,N-Dimethylformamide was added; then, the mixture was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 10 mL of 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 1H-imidazole-l -sulfonyl azide hydrochloride (3.0 equiv.) and N,N-Diisopropylethylamine (6.0 equiv.) were mixed in dichloromethane. The mixture was drawn into the reaction vessel and reacted under nitrogen for 1 hr to convert amine to azide. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. Tetrakis(acetonitrile)copper(I) hexafluorophosphate (0.2 equiv.) was added directly into the peptide synthesis vessel to perform on-resin "click" reaction. The mixture of ethynylcyclopropane (5.0 equiv.), N,N-Diisopropylethylamine (10.0 equiv.) in 10 mL N,N-Dimethylformamide (nitrogen purged) was drawn into the reaction vessel and reacted overnight under nitrogen. The resin was washed with 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. A cleavage solution was prepared by mixing 5% Triisopropylsilane in 95% Trifluoroacetic acid. The solution was drawn into the reaction vessel and reacted for 1 hr. The Trifluoroacetic acid was removed under vacuum. The remaining residue was mixed with 50 mL cold ether (-20 °C) to precipitate the compound. The precipitate was collected and separated by reverse phase HPLC (30% - 60% Acetonitrile). The desired product was freeze dried and characterized by LC-MS. ESI-MS: m/z [M+H]+ calculated: 649.3, found: 649.3. [0383] 1H NMR (400 MHz, DMSO-d6) 5 9.04 (s, 1H), 8.62 (d, J = 7.3 Hz, 1H), 7.99 (s, 1H), 7.53 (d, 7 = 1.2 Hz, 1H), 7.51 - 7.45 (m, 2H), 5.25 (s, 1H), 5.17 (h, 7 = 6.9 Hz, 1H), 4.28 (dt, 7 = 5.6, 2.7 Hz, 2H), 3.71 - 3.51 (m, 2H), 2.47 (s, 3H), 2.11 (dd, 7 = 12.9, 7.9 Hz, 1H), 2.03 - 1.88 (m, 4H), 1.80 - 1.56 (m, 8H), 1.55 - 1.42 (m, 7H), 1.39 (d, 7 = 7.0 Hz, 3H), 0.89 (dd, 7 = 8.4, 2.4 Hz, 2H), 0.80 - 0.69 (m, 2H).
Stage #1: C21H22ClN2O2PolS; (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2-carboxylic acid With 1-hydroxy-7-aza-benzotriazole; N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide for 2h; Inert atmosphere; Stage #2: With 4-methylpiperidine In N,N-dimethyl-formamide Inert atmosphere; Stage #3: (2S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-(adamantan-1-yl)acetic acid Further stages; S23 4-Formy1-3-methoxy-phenyloxymethyl polystyrene resin (0.100 mmol) was added to a plastic peptide synthesis vessel. 10 mL 1,2-Dichloroethane were added and the resin was allowed to swell for 30 min under nitrogen. The resin was drained under vacuum. 1-[2-chloro-4-(4-methyl-1,3-thiazo1-5-yl)phenyl]ethan-1-amine diHydrochloride (3.0 equiv.) was added to the plastic reactor. A solution of triethylamine (10.0 equiv.) in 1,2-Dichloroe thane (1 mL) was prepared. The solution was drawn into the plastic reactor and reacted for 2 hr at room temperature. The reactor was opened, and sodium cyanoborohydride (10.0 equiv.) and acetic acid (2 equiv.) were added to the reactor. The reactor was left opened on manifold, mixed by pipetting, and reacted overnight at RT. The resin was washed by lOmL methanol, 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture of (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2-carboxylic acid (3.0 equiv.), 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (3.0 equiv.), 1-hydroxy-7-azabenzotriazole (3.0 equiv.), and N,N- Diisopropylethylamine (6.0 equiv.) in 10 mL N,N-Dimethylformamide was added; then, the mixture was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 10 mL of 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture (2S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-(adamantan-1-yl)acetic acid (3.0 equiv.), Ethyl cyano(hydroxyimino) acetate (3.0 equiv.) and N,N'-Diisopropylcarbodiimide (3.0 equiv.) in 10 mL N,N-Dimethylformamide was added; then, the mixture was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 10 mL of 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 1H-imidazole-l -sulfonyl azide hydrochloride (3.0 equiv.) and N,N-Diisopropylethylamine (6.0 equiv.) were mixed in dichloromethane. The mixture was drawn into the reaction vessel and reacted under nitrogen for 1 hr to convert amine to azide. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. Tetrakis(acetonitrile)copper(I) hexafluorophosphate (0.2 equiv.) was added directly into the peptide synthesis vessel to perform on-resin "click" reaction. The mixture of ethynylcyclopropane (5.0 equiv.), N,N-Diisopropylethylamine (10.0 equiv.) in 10 mL N,N-Dimethylformamide (nitrogen purged) was drawn into the reaction vessel and reacted overnight under nitrogen. The resin was washed with 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. A cleavage solution was prepared by mixing 5% Triisopropylsilane in 95% Trifluoroacetic acid. The solution was drawn into the reaction vessel and reacted for 1 hr. The Trifluoroacetic acid was removed under vacuum. The remaining residue was mixed with 50 mL cold ether (-20 °C) to precipitate the compound. The precipitate was collected and separated by reverse phase HPLC (30% - 60% Acetonitrile). The desired product was freeze dried and characterized by LC-MS. ESI-MS: m/z [M+H]+ calculated: 649.3, found: 649.3. [0383] 1H NMR (400 MHz, DMSO-d6) 5 9.04 (s, 1H), 8.62 (d, J = 7.3 Hz, 1H), 7.99 (s, 1H), 7.53 (d, 7 = 1.2 Hz, 1H), 7.51 - 7.45 (m, 2H), 5.25 (s, 1H), 5.17 (h, 7 = 6.9 Hz, 1H), 4.28 (dt, 7 = 5.6, 2.7 Hz, 2H), 3.71 - 3.51 (m, 2H), 2.47 (s, 3H), 2.11 (dd, 7 = 12.9, 7.9 Hz, 1H), 2.03 - 1.88 (m, 4H), 1.80 - 1.56 (m, 8H), 1.55 - 1.42 (m, 7H), 1.39 (d, 7 = 7.0 Hz, 3H), 0.89 (dd, 7 = 8.4, 2.4 Hz, 2H), 0.80 - 0.69 (m, 2H).
Stage #1: C21H22ClN2O2PolS; (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2-carboxylic acid With 1-hydroxy-7-aza-benzotriazole; N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide for 2h; Inert atmosphere; Stage #2: With 4-methylpiperidine In N,N-dimethyl-formamide Inert atmosphere; Stage #3: (2S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-(adamantan-1-yl)acetic acid Further stages; S23 4-Formy1-3-methoxy-phenyloxymethyl polystyrene resin (0.100 mmol) was added to a plastic peptide synthesis vessel. 10 mL 1,2-Dichloroethane were added and the resin was allowed to swell for 30 min under nitrogen. The resin was drained under vacuum. 1-[2-chloro-4-(4-methyl-1,3-thiazo1-5-yl)phenyl]ethan-1-amine diHydrochloride (3.0 equiv.) was added to the plastic reactor. A solution of triethylamine (10.0 equiv.) in 1,2-Dichloroe thane (1 mL) was prepared. The solution was drawn into the plastic reactor and reacted for 2 hr at room temperature. The reactor was opened, and sodium cyanoborohydride (10.0 equiv.) and acetic acid (2 equiv.) were added to the reactor. The reactor was left opened on manifold, mixed by pipetting, and reacted overnight at RT. The resin was washed by lOmL methanol, 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture of (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2-carboxylic acid (3.0 equiv.), 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (3.0 equiv.), 1-hydroxy-7-azabenzotriazole (3.0 equiv.), and N,N- Diisopropylethylamine (6.0 equiv.) in 10 mL N,N-Dimethylformamide was added; then, the mixture was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 10 mL of 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture (2S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-(adamantan-1-yl)acetic acid (3.0 equiv.), Ethyl cyano(hydroxyimino) acetate (3.0 equiv.) and N,N'-Diisopropylcarbodiimide (3.0 equiv.) in 10 mL N,N-Dimethylformamide was added; then, the mixture was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 10 mL of 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 1H-imidazole-l -sulfonyl azide hydrochloride (3.0 equiv.) and N,N-Diisopropylethylamine (6.0 equiv.) were mixed in dichloromethane. The mixture was drawn into the reaction vessel and reacted under nitrogen for 1 hr to convert amine to azide. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. Tetrakis(acetonitrile)copper(I) hexafluorophosphate (0.2 equiv.) was added directly into the peptide synthesis vessel to perform on-resin "click" reaction. The mixture of ethynylcyclopropane (5.0 equiv.), N,N-Diisopropylethylamine (10.0 equiv.) in 10 mL N,N-Dimethylformamide (nitrogen purged) was drawn into the reaction vessel and reacted overnight under nitrogen. The resin was washed with 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. A cleavage solution was prepared by mixing 5% Triisopropylsilane in 95% Trifluoroacetic acid. The solution was drawn into the reaction vessel and reacted for 1 hr. The Trifluoroacetic acid was removed under vacuum. The remaining residue was mixed with 50 mL cold ether (-20 °C) to precipitate the compound. The precipitate was collected and separated by reverse phase HPLC (30% - 60% Acetonitrile). The desired product was freeze dried and characterized by LC-MS. ESI-MS: m/z [M+H]+ calculated: 649.3, found: 649.3. [0383] 1H NMR (400 MHz, DMSO-d6) 5 9.04 (s, 1H), 8.62 (d, J = 7.3 Hz, 1H), 7.99 (s, 1H), 7.53 (d, 7 = 1.2 Hz, 1H), 7.51 - 7.45 (m, 2H), 5.25 (s, 1H), 5.17 (h, 7 = 6.9 Hz, 1H), 4.28 (dt, 7 = 5.6, 2.7 Hz, 2H), 3.71 - 3.51 (m, 2H), 2.47 (s, 3H), 2.11 (dd, 7 = 12.9, 7.9 Hz, 1H), 2.03 - 1.88 (m, 4H), 1.80 - 1.56 (m, 8H), 1.55 - 1.42 (m, 7H), 1.39 (d, 7 = 7.0 Hz, 3H), 0.89 (dd, 7 = 8.4, 2.4 Hz, 2H), 0.80 - 0.69 (m, 2H).
  • 17
  • [ 1221793-29-8 ]
  • [ 122996-47-8 ]
  • [ 205526-38-1 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
Stage #1: (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-([1,1'-biphenyl]-4-yl)propanoic acid With ethyl (hydroxyimino)cyanoacetate; diisopropyl-carbodiimide In N,N-dimethyl-formamide for 2h; Inert atmosphere; Stage #2: With 4-methylpiperidine In N,N-dimethyl-formamide Inert atmosphere; Stage #3: (2S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-(adamantan-1-yl)acetic acid; (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2-carboxylic acid Further stages; S8 Rink Amide Resin (0.100 mmol) was added to a plastic peptide synthesis vessel. 10 mL N,N-Dimethylformamide was added and the resin was allowed to swell for 30 min under nitrogen. The resin was drained under vacuum. 10 mL of 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel, and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum, and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture of (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-([1,1'-biphenyl]-4-yl)propanoic acid (3.0 equiv.), Ethyl cyano(hydroxyimino)acetate (3.0 equiv.) and N,N'- Diisopropylcarbodiimide (3.0 equiv.) in 10 mL N,N-Dimethylformamide was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated for 3 times. 10 mL 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture of (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2- carboxylic acid (3.0 equiv.), Ethyl cyano(hydroxyimino)acetate (3.0 equiv.) and N,N'- Diisopropylcarbodiimide (3.0 equiv.) in 10 mL N,N-Dimethylformamide was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 10 mL 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture of (2S)-2-((((9H- fhioren-9-yl)methoxy)carbonyl)amino)-2-(adamantan-1-yl)acetic acid (3.0 equiv.), Ethyl cyano(hydroxyimino)acetate (3.0 equiv.) and N,N'-Diisopropylcarbodiimide (3.0 equiv.) in 10 mL N,N-Dimethylformamide was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 10 mL of 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 1H-imidazole-1-sulfonyl azide hydrochloride (3.0 equiv.) and N,N-Diisopropylethylamine (6.0 equiv.) were mixed in dichloromethane. The mixture was drawn into the reaction vessel and reacted under nitrogen for 1 hr to convert amine to azide. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. Tetrakis(acetonitrile)copper(I) hexafluorophosphate (0.2 equiv.) was added directly into the peptide synthesis vessel to perform on-resin "click" reaction. The mixture of ethynylcyclopropane (5.0 equiv.), N,N- Diisopropylethylamine (10.0 equiv.) in 10 mL N,N-Dimethylformamide (nitrogen purged) was drawn into the reaction vessel and reacted overnight under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. A cleavage solution was prepared by mixing 5% Triisopropylsilane in 95% Trifluoroacetic acid. The solution was drawn into the reaction vessel and reacted for 1 hr. Trifluoroacetic acid was removed under vacuum. The remaining residue was mixed with 50 mL cold ether (-20 °C) to precipitate the compound. The precipitate was collected and separated by reverse phase HPLC (30%-60% Acetonitrile). The desired product was freeze dried and characterized by LC-MS. ESI-MS: m/z [M+H]+ calculated: 637.3, found: 637.3. [0338] 1H NMR (400 MHz, MeOH-d4) 5 7.97 - 7.87 (m, 1H), 7.62 - 7.48 (m, 4H), 7.45 - 7.37 (m, 2H), 7.34 (s, 1H), 7.33 - 7.23 (m, 2H), 5.25 (s, 1H), 4.75 - 4.63 (m, 1H), 4.45 - 4.31 (m, 2H), 3.81 (dd, 7= 11.1, 3.6 Hz, 1H), 3.74 - 3.60 (m, 1H), 3.47 (dd, 7= 14.2, 4.0 Hz, 1H), 2.85 (dd, 7 = 14.2, 11.1 Hz, 1H), 2.01 - 1.87 (m, 5H), 1.80 - 1.65 (m, 7H), 1.59 (t, 7 = 14.7 Hz, 6H), 1.01 - 0.90 (m, 2H), 0.82 - 0.67 (m, 2H).
Stage #1: (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-([1,1'-biphenyl]-4-yl)propanoic acid With ethyl (hydroxyimino)cyanoacetate; diisopropyl-carbodiimide In N,N-dimethyl-formamide for 2h; Inert atmosphere; Stage #2: With 4-methylpiperidine In N,N-dimethyl-formamide Inert atmosphere; Stage #3: (2S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-(adamantan-1-yl)acetic acid; (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2-carboxylic acid Further stages; S8 Rink Amide Resin (0.100 mmol) was added to a plastic peptide synthesis vessel. 10 mL N,N-Dimethylformamide was added and the resin was allowed to swell for 30 min under nitrogen. The resin was drained under vacuum. 10 mL of 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel, and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum, and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture of (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-([1,1'-biphenyl]-4-yl)propanoic acid (3.0 equiv.), Ethyl cyano(hydroxyimino)acetate (3.0 equiv.) and N,N'- Diisopropylcarbodiimide (3.0 equiv.) in 10 mL N,N-Dimethylformamide was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated for 3 times. 10 mL 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture of (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2- carboxylic acid (3.0 equiv.), Ethyl cyano(hydroxyimino)acetate (3.0 equiv.) and N,N'- Diisopropylcarbodiimide (3.0 equiv.) in 10 mL N,N-Dimethylformamide was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 10 mL 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture of (2S)-2-((((9H- fhioren-9-yl)methoxy)carbonyl)amino)-2-(adamantan-1-yl)acetic acid (3.0 equiv.), Ethyl cyano(hydroxyimino)acetate (3.0 equiv.) and N,N'-Diisopropylcarbodiimide (3.0 equiv.) in 10 mL N,N-Dimethylformamide was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 10 mL of 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 1H-imidazole-1-sulfonyl azide hydrochloride (3.0 equiv.) and N,N-Diisopropylethylamine (6.0 equiv.) were mixed in dichloromethane. The mixture was drawn into the reaction vessel and reacted under nitrogen for 1 hr to convert amine to azide. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. Tetrakis(acetonitrile)copper(I) hexafluorophosphate (0.2 equiv.) was added directly into the peptide synthesis vessel to perform on-resin "click" reaction. The mixture of ethynylcyclopropane (5.0 equiv.), N,N- Diisopropylethylamine (10.0 equiv.) in 10 mL N,N-Dimethylformamide (nitrogen purged) was drawn into the reaction vessel and reacted overnight under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. A cleavage solution was prepared by mixing 5% Triisopropylsilane in 95% Trifluoroacetic acid. The solution was drawn into the reaction vessel and reacted for 1 hr. Trifluoroacetic acid was removed under vacuum. The remaining residue was mixed with 50 mL cold ether (-20 °C) to precipitate the compound. The precipitate was collected and separated by reverse phase HPLC (30%-60% Acetonitrile). The desired product was freeze dried and characterized by LC-MS. ESI-MS: m/z [M+H]+ calculated: 637.3, found: 637.3. [0338] 1H NMR (400 MHz, MeOH-d4) 5 7.97 - 7.87 (m, 1H), 7.62 - 7.48 (m, 4H), 7.45 - 7.37 (m, 2H), 7.34 (s, 1H), 7.33 - 7.23 (m, 2H), 5.25 (s, 1H), 4.75 - 4.63 (m, 1H), 4.45 - 4.31 (m, 2H), 3.81 (dd, 7= 11.1, 3.6 Hz, 1H), 3.74 - 3.60 (m, 1H), 3.47 (dd, 7= 14.2, 4.0 Hz, 1H), 2.85 (dd, 7 = 14.2, 11.1 Hz, 1H), 2.01 - 1.87 (m, 5H), 1.80 - 1.65 (m, 7H), 1.59 (t, 7 = 14.7 Hz, 6H), 1.01 - 0.90 (m, 2H), 0.82 - 0.67 (m, 2H).
  • 18
  • [ CAS Unavailable ]
  • [ 1221793-29-8 ]
  • [ 122996-47-8 ]
  • [ 205526-38-1 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
Stage #1: Rink-amide MBHA resin; (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-([1,1'-biphenyl]-4-yl)propanoic acid With ethyl (hydroxyimino)cyanoacetate; diisopropyl-carbodiimide In N,N-dimethyl-formamide for 2h; Inert atmosphere; Stage #2: With 4-methylpiperidine In N,N-dimethyl-formamide Inert atmosphere; Stage #3: (2S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-(adamantan-1-yl)acetic acid; (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2-carboxylic acid Further stages; S8 Rink Amide Resin (0.100 mmol) was added to a plastic peptide synthesis vessel. 10 mL N,N-Dimethylformamide was added and the resin was allowed to swell for 30 min under nitrogen. The resin was drained under vacuum. 10 mL of 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel, and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum, and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture of (R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-([1,1'-biphenyl]-4-yl)propanoic acid (3.0 equiv.), Ethyl cyano(hydroxyimino)acetate (3.0 equiv.) and N,N'- Diisopropylcarbodiimide (3.0 equiv.) in 10 mL N,N-Dimethylformamide was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated for 3 times. 10 mL 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture of (2S,4R)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxy)pyrrolidine-2- carboxylic acid (3.0 equiv.), Ethyl cyano(hydroxyimino)acetate (3.0 equiv.) and N,N'- Diisopropylcarbodiimide (3.0 equiv.) in 10 mL N,N-Dimethylformamide was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 10 mL 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. A mixture of (2S)-2-((((9H- fhioren-9-yl)methoxy)carbonyl)amino)-2-(adamantan-1-yl)acetic acid (3.0 equiv.), Ethyl cyano(hydroxyimino)acetate (3.0 equiv.) and N,N'-Diisopropylcarbodiimide (3.0 equiv.) in 10 mL N,N-Dimethylformamide was drawn into the synthesis vessel and reacted for 2 hr under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 10 mL of 20% 4-methylpiperidine in N,N-Dimethylformamide were drawn into the reaction vessel and reacted under nitrogen for 15 min to deprotect Fmoc group. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N- Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. 1H-imidazole-1-sulfonyl azide hydrochloride (3.0 equiv.) and N,N-Diisopropylethylamine (6.0 equiv.) were mixed in dichloromethane. The mixture was drawn into the reaction vessel and reacted under nitrogen for 1 hr to convert amine to azide. The solvent was drained under vacuum and the deprotection was repeated. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. The washing procedure was repeated 3 times. Tetrakis(acetonitrile)copper(I) hexafluorophosphate (0.2 equiv.) was added directly into the peptide synthesis vessel to perform on-resin "click" reaction. The mixture of ethynylcyclopropane (5.0 equiv.), N,N- Diisopropylethylamine (10.0 equiv.) in 10 mL N,N-Dimethylformamide (nitrogen purged) was drawn into the reaction vessel and reacted overnight under nitrogen. The resin was washed with 10 mL N,N-Dimethylformamide, then 10 mL dichloromethane, and drained under vacuum. A cleavage solution was prepared by mixing 5% Triisopropylsilane in 95% Trifluoroacetic acid. The solution was drawn into the reaction vessel and reacted for 1 hr. Trifluoroacetic acid was removed under vacuum. The remaining residue was mixed with 50 mL cold ether (-20 °C) to precipitate the compound. The precipitate was collected and separated by reverse phase HPLC (30%-60% Acetonitrile). The desired product was freeze dried and characterized by LC-MS. ESI-MS: m/z [M+H]+ calculated: 637.3, found: 637.3. [0338] 1H NMR (400 MHz, MeOH-d4) 5 7.97 - 7.87 (m, 1H), 7.62 - 7.48 (m, 4H), 7.45 - 7.37 (m, 2H), 7.34 (s, 1H), 7.33 - 7.23 (m, 2H), 5.25 (s, 1H), 4.75 - 4.63 (m, 1H), 4.45 - 4.31 (m, 2H), 3.81 (dd, 7= 11.1, 3.6 Hz, 1H), 3.74 - 3.60 (m, 1H), 3.47 (dd, 7= 14.2, 4.0 Hz, 1H), 2.85 (dd, 7 = 14.2, 11.1 Hz, 1H), 2.01 - 1.87 (m, 5H), 1.80 - 1.65 (m, 7H), 1.59 (t, 7 = 14.7 Hz, 6H), 1.01 - 0.90 (m, 2H), 0.82 - 0.67 (m, 2H).
Same Skeleton Products
Historical Records